# Predictive Value of NT-proBNP on MACEs After Acute Coronary Syndrome

> **NCT06569511** · — · COMPLETED · sponsor: **Haseki Training and Research Hospital** · enrollment: 241 (actual)

## Conditions studied

- Acute Coronary Syndrome
- ST-segment Elevation Myocardial Infarction (STEMI)
- Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
- Major Adverse Cardiac Events

## Interventions

- **DIAGNOSTIC_TEST:** N-terminal pro-B-type natriuretic peptide (NT-proBNP)
- **DIAGNOSTIC_TEST:** high sensitive cardiac troponin T (hs-cTnT)

## Key facts

- **NCT ID:** NCT06569511
- **Lead sponsor:** Haseki Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-01
- **Primary completion:** 2024-02-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2024-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06569511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06569511, "Predictive Value of NT-proBNP on MACEs After Acute Coronary Syndrome". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06569511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*